< Back to Publications & Resources
Elevate Your Practice: Curated Insights for Your Medical Office
Navigating the ever-expanding volume of information in the medical field can be a daunting task. How do you efficiently discern critical insights that truly make a difference in your daily practice? At MLMIC, we recognize this challenge. That is why we have meticulously compiled a selection of vital articles, providing you with clear, concise summaries and direct access to the most impactful industry news and analysis. Think of this as your essential guide to staying sharp and comprehensively informed.
Join us as we explore our curations for the month of October.
Several Types of Cancer are Tied to Preventable Infections
According to a new study published in The Lancet Oncology, about 1 in 8 cancer cases worldwide (roughly 2.3 million cases in 2024) were linked to infections, many of which are preventable or treatable. The biggest contributors were H. pylori (associated with stomach cancer) and HPV (associated with cervical cancer), highlighting how vaccinations, screening and early treatment could help reduce millions of future cancer cases.
For healthcare organizations, the findings reinforce the importance of preventive care and public health measures, as several of the leading infection-related cancers may be avoidable through established vaccination, testing and treatment programs.
The FDA Flags Four Deaths as Potential Safety Signal for Schizophrenia Medication, Evenamide
The FDA has identified four deaths among patients receiving the investigational schizophrenia drug Evenamide as a potential safety signal, prompting an ongoing clinical hold on U.S. trial sites. While investigators determined that three of the deaths were unrelated to the drug and one was only possibly related, the FDA said a potentially fatal heart rhythm abnormality could not be ruled out and is requiring further safety evaluation.
Newron Pharmaceuticals maintains that its clinical data have not shown a pattern of cardiac abnormalities and is working with the FDA to review the findings while continuing enrollment in study sites outside the United States.
Artificial Intelligence May Predict Pancreatic Cancer Five Years Before Diagnosis
Researchers at the Mayo Clinic have developed an AI model that analyzes routine electronic health records and lab results to identify people at higher risk for pancreatic cancer up to five years before diagnosis. The model showed promising accuracy in distinguishing higher- and lower-risk patients, potentially offering a way to detect this often-deadly cancer earlier when treatment is more effective.
While the results are encouraging, the technology is still being studied and has not yet been approved for routine clinical use. Researchers are conducting further testing to determine how well the model performs in real-world healthcare settings and whether it can improve early detection and patient outcomes.
Pediatricians Endorse Ban on Raw Milk Products
The American Academy of Pediatrics is calling for a nationwide ban on raw (unpasteurized) milk and dairy products, citing evidence that they can cause serious and potentially life-threatening illnesses, particularly in children, pregnant people and other vulnerable populations. The organization points to numerous outbreaks linked to raw dairy products and notes that pasteurization is the only reliable way to eliminate harmful pathogens.
The policy statement also pushes back against claims that raw milk offers unique health benefits, saying those assertions are not supported by scientific evidence. Pediatricians are encouraging lawmakers and public health officials to strengthen restrictions on raw dairy products to help prevent future illnesses and outbreaks.
As healthcare continues to evolve, staying informed is one of the best ways to strengthen your practice and better serve your patients. We hope this edition of Elevate Your Practice has provided valuable insights and practical strategies you can put into action. Be sure to check back next month for more expert guidance, industry updates, and resources from MLMIC.
Follow us on LinkedIn, Twitter, Facebook or Instagram to stay in the loop about the medical professional liability industry.
If you are not already a MLMIC insured, learn more about us here.
This document is for general purposes only and should not be construed as medical, dental, or legal advice. This document is not comprehensive and does not cover all possible factual circumstances. Because the facts applicable to your situation may vary, or the laws applicable in your jurisdiction may differ, please contact your attorney or other professional advisors for any questions related to legal, medical, dental, or professional obligations, the applicable state or federal laws or other professional questions.
